$CORV on NASDAQ
May 21, 2020
Correvio Obtains Final Order for Plan of Arrangement
May 15, 2020
Correvio Announces Results from Annual General and Special Meeting of Securityholders
May 06, 2020
Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVANZ PHARMA
May 04, 2020
Correvio Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19
May 01, 2020
Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA
April 20, 2020
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Are Shareholders Getting a Fair Deal?
April 08, 2020
Correvio Obtains Interim Order For Plan Of Arrangement
March 30, 2020
Correvio Reports Full Year 2019 Financial Results
March 16, 2020
ADVANZ PHARMA to Acquire Correvio
March 10, 2020
Correvio Partners with Hong Kong Teson Pharma Limited for the Commercialization of Aggrastat® in China
March 02, 2020
Correvio Responds to Market Activity
January 28, 2020
Correvio Receives NASDAQ Notification Regarding Deficiencies In Minimum Bid Price And Market Value Of Listed Securities
December 24, 2019
Correvio Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events
December 11, 2019
Correvio Announces Intention to Explore Strategic Alternatives to Maximize Stakeholder Value
December 10, 2019
Correvio Announces Outcome Of FDA Advisory Committee Meeting Reviewing Brinavess™ For The Treatment Of Recent Onset Atrial Fibrillation
December 10, 2019
Correvio Stock Trading Halted Today; FDA Advisory Committee Meeting To Discuss Brinavess™ For Recent Onset Atrial Fibrillation
November 25, 2019
Correvio to Present at the Piper Jaffray 31st Annual Healthcare Conference
November 18, 2019
Correvio Announces Presentation of New Brinavess™ Spectrum Data at the American Heart Association 2019 Annual Meeting
November 14, 2019
Correvio Reports Third Quarter 2019 Financial Results
November 07, 2019
Correvio to Report Third Quarter 2019 Financial Results
November 04, 2019
Correvio Announces FDA Advisory Committee Meeting to Review Brinavess™ for Recent Onset Atrial Fibrillation
September 27, 2019
Correvio to Present at the 2019 Cantor Global Healthcare Conference
September 12, 2019
Correvio Highlights FDA Acceptance of United Therapeutics' Trevyent New Drug Application
September 04, 2019
Correvio to Present at the H.C. Wainwright 21st Annual Global Investment Conference
September 03, 2019
Correvio Announces Presentation Of Brinavess® Spectrum Data At The European Society Of Cardiology 2019 Congress
August 14, 2019
Correvio Reports Second Quarter 2019 Financial Results
August 12, 2019
Correvio Announces Brinavess® Spectrum Data to be Presented at the European Society of Cardiology 2019 Congress
August 08, 2019
Correvio to Report Second Quarter 2019 Financial Results
August 07, 2019
Correvio Closes Public Offering of 9,200,000 Common Shares
August 02, 2019
Correvio Announces Pricing Of Public Offering Of Common Shares
August 01, 2019
Correvio Announces Overnight Marketed Offering of Common Shares
July 25, 2019
U.S. FDA Accepts Correvio's Resubmitted New Drug Application For Brinavess (vernakalant)
June 24, 2019
Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation
June 18, 2019
Correvio Announces Voting Results
May 01, 2019
Correvio to Report First Quarter 2019 Financial Results on May 8, 2019
April 03, 2019
Correvio Announces Zevtera® Abstracts at ECCMID 2019
April 03, 2019
Correvio Announces Xydalba(TM) (Dalbavancin Hydrochloride) Abstracts at ECCMID 2019
April 02, 2019
Correvio to present at the H.C. Wainwright Global Life Sciences Conference
March 20, 2019
Correvio Announces Presentation Of Brinavess® Data At The American College Of Cardiology 2019 Annual Meeting
March 14, 2019
Correvio Announces at the Market Offering
March 13, 2019
Correvio Reports Fourth Quarter and Full Year 2018 Financial Results
March 11, 2019
Correvio Announces Amendment To Term Loan With CRG-Managed Funds
March 07, 2019
Correvio to Present at Upcoming Investor Conferences
March 06, 2019
Correvio To Report Fourth Quarter And Full Year 2018 Financial Results On March 13, 2019
February 21, 2019
Correvio to Participate in the 8th Annual SVB Leerink Global Healthcare Conference
- No Recent Filings Found.
